BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11366764)

  • 1. New protease inhibitor.
    Vazquez E
    Posit Aware; 1999; 10(3):24. PubMed ID: 11366764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amprenavir approved.
    STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amprenavir, new protease inhibitor, approved.
    James JS
    AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What they say about protease inhibitors.
    Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study: new drug doesn't display cross-resistance.
    AIDS Alert; 1999 Jul; 14(7):77. PubMed ID: 11366418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amprenavir (Agenerase).
    Simmons P
    Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amprenavir (Agenerase).
    Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
    [No Abstract]   [Full Text] [Related]  

  • 8. New treatment options.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug approval.
    AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 11. Glaxo Wellcome's two new drugs.
    Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 13. Amping amprenavir with ritonavir.
    TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amprenavir (AGENERASE) oral solution: warning for some patients.
    AIDS Treat News; 2000 May; (342):3. PubMed ID: 12870457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amprenavir: a new HIV protease inhibitor.
    Med Lett Drugs Ther; 1999 Jul; 41(1057):64-6. PubMed ID: 10436772
    [No Abstract]   [Full Text] [Related]  

  • 17. Amprenavir (Agenerase) now available in expanded access.
    AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials for protease failure.
    Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
    Highleyman L
    BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amprenavir: new preparation. Another HIV protease inhibitor: no proven advance.
    Prescrire Int; 2001 Jun; 10(53):70-2. PubMed ID: 11718166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.